DUBLIN, Dec. 22, 2023 /PRNewswire/ — The “Global Point-of-care Testing Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering.
This study provides an overview of the global point-of-care testing (POCT) industry, which refers to any routine or specialized lab pathology testing conducted rapidly, on-site/near the site of the patient, where care or treatment is provided. COVID-19 radicalization is changing the global diagnostics landscape. Consolidation trends, structural shifts in healthcare settings, and the extension of POCT to sexually transmitted infections (STIs), antimicrobial resistance (AMR), routine testing, oncology, and newborn screening are shaping new frontiers. In the future, therapy areas such as oncology, stroke, and dementia will represent the POCT repertoire.
In developed economies, the proliferation of syndromic testing, multiplexing making inroads in immunoassay, evolution in nucleic acid amplification technology (from PCR to Isothermal Amplification), the use of saliva specimens, and advancements in antimicrobial resistance testing are increasing the market viability. Furthermore, AI/ML-enabled device software functions incorporating predetermined change control plans under the diagnostic data program initiative offer accelerated market opportunities in the United States.
In developing economies, multiparametric platforms have emerged to respond to an escalating POC demand in emergency departments and small-medium labs. In addition, a strong pull toward preventive health is laying the foundation to advance routine testing using emerging blood testing platforms.
A robust multiplex ecosystem tied with the converging potential of diagnostic data creating new revenue streams (e.g., connectivity and digital healthcare technology services) exemplifies the pivot from COVID-19 testing, adapting to changing clinical pathways and greater harmonization of lab-based and non-lab-based diagnostic data for similar tests to build a more sustainable point-of-care ecosystem.
Key Topics Covered:
Growth Opportunity Analysis
- Scope of Analysis
- Segmentation – Test Type
- Segmentation – Care Continuum
- Key Competitors
- Growth Metrics
- Growth Drivers
- Growth Restraints
- Forecast Assumptions
- Revenue Forecast
- Revenue Forecast by Test Type
- Revenue Forecast by Region
- Revenue Forecast by Care Continuum
- Forecast Analysis
- Pricing Trends and Forecast Analysis
- Competitive Environment
- POCT Across Different Therapy Areas
- Revenue Share
- Revenue Share Analysis
- Competitor Matrix – Therapy Areas
- Competitor Matrix – Technology Mapping
Growth Opportunity Analysis – Immunochemistry POCT
- Growth Metrics
- Revenue Forecast
- Revenue Forecast by Region
- Revenue Forecast by Immunochemistry POCT
- Forecast Analysis
Growth Opportunity Analysis – Molecular POCT
- Growth Metrics
- Revenue Forecast
- Revenue Forecast by Region
- Revenue Forecast by Molecular POCT Therapy Areas
- Forecast Analysis
Growth Opportunity Universe
- Growth Opportunity 1: Molecular POCT
- Growth Opportunity 2: Multiplexing
- Growth Opportunity 3: STI POCT
- Growth Opportunity 4: AMR POCT
- Growth Opportunity 5: Routine POCT
- Growth Opportunity 6: Smartphone POCT
- Future of POCT in Care Continuum
For more information about this report visit https://www.researchandmarkets.com/r/uho43y
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
